ConductScience.org, home

Paper139409

Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor.

Moss J and 1 other. J Biol Chem, 1977. Cited by 335 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor. Papers, record 139409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/139409

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor.
PubMed
Journal
J Biol Chem
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
335
iCite
Relative citation ratio, by iCite
7.67
iCite
Revised in PubMed
2021-02-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Moss JJ
2Vaughan MM

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacterial ToxinsMajor topic
PentosyltransferasesMajor topic
Vibrio choleraeMajor topic
Adenosine Diphosphate Sugars
Arginine
Binding Sites
Niacinamide
Protein Binding
Ribose

Source PubMed

Cited by80

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 335 citations.

PMIDTitleJournalYearIn PapersSource
40,273,333Kinetic Mechanism of the Emergent Anticancer Target, Human ADP-ribosyltransferase 1.Biochemistry2025https://conductscience.org/library/papers/40273333PubMed
39,637,178Administration of novobiocin and apomorphine mitigates cholera toxin mediated cellular toxicity: Lessons from cholera toxin yeast model system.PLoS One2024https://conductscience.org/library/papers/39637178PubMed
39,591,223An Emerging Way for Bacteria to Engage with Host Cells via Protein ADP-riboxanation.Toxins (Basel)2024https://conductscience.org/library/papers/39591223PubMed
39,145,455The forgotten pandemic: how understanding cholera illuminated mechanisms of chloride channels in multiple diseases.J Clin Invest2024https://conductscience.org/library/papers/39145455PubMed
37,939,374Synthetic Dual Cysteine-ADP Ribosylated Peptides from the Androgen Receptor are Recognized by the DTX3L/PARP9 Complex.ACS Chem Biol2023https://conductscience.org/library/papers/37939374PubMed
36,497,109ARH Family of ADP-Ribose-Acceptor Hydrolases.Cells2022https://conductscience.org/library/papers/36497109PubMed
35,175,282Beyond protein modification: the rise of non-canonical ADP-ribosylation.Biochem J2022https://conductscience.org/library/papers/35175282PubMed
34,969,853PKD-dependent PARP12-catalyzed mono-ADP-ribosylation of Golgin-97 is required for E-cadherin transport from Golgi to plasma membrane.Proc Natl Acad Sci U S A2022https://conductscience.org/library/papers/34969853PubMed
32,966,781Mapping Physiological ADP-Ribosylation Using Activated Ion Electron Transfer Dissociation.Cell Rep2020https://conductscience.org/library/papers/32966781PubMed
32,092,898ARH1 in Health and Disease.Cancers (Basel)2020https://conductscience.org/library/papers/32092898PubMed
30,798,302An Advanced Strategy for Comprehensive Profiling of ADP-ribosylation Sites Using Mass Spectrometry-based Proteomics.Mol Cell Proteomics2019https://conductscience.org/library/papers/30798302PubMed
29,043,790Emissive Synthetic Cofactors: An Isomorphic, Isofunctional, and Responsive NAD+ Analogue.J Am Chem Soc2017https://conductscience.org/library/papers/29043790PubMed
23,382,240Arginine ADP-ribosylation mechanism based on structural snapshots of iota-toxin and actin complex.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/23382240PubMed
22,879,887Arginine-specific mono ADP-ribosylation in vitro of antimicrobial peptides by ADP-ribosylating toxins.PLoS One2012https://conductscience.org/library/papers/22879887PubMed
19,897,717ADP-ribosylation of human defensin HNP-1 results in the replacement of the modified arginine with the noncoded amino acid ornithine.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19897717PubMed
19,895,577Side chain specificity of ADP-ribosylation by a sirtuin.FEBS J2009https://conductscience.org/library/papers/19895577PubMed
19,744,927Identification of an iron-sulfur cluster that modulates the enzymatic activity in NarE, a Neisseria meningitidis ADP-ribosyltransferase.J Biol Chem2009https://conductscience.org/library/papers/19744927PubMed
17,707,545"Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?Adv Drug Deliv Rev2007https://conductscience.org/library/papers/17707545PubMed
17,526,733Enhanced sensitivity to cholera toxin in ADP-ribosylarginine hydrolase-deficient mice.Mol Cell Biol2007https://conductscience.org/library/papers/17526733PubMed
17,146,673C3 exoenzymes, novel insights into structure and action of Rho-ADP-ribosylating toxins.Naunyn Schmiedebergs Arch Pharmacol2007https://conductscience.org/library/papers/17146673PubMed

See all 80 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/139409

GET https://conductscience.org/api/papers/v1/139409/cited_by?page=2